verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: glenmark pharmaceuticals inc., usa
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler glenmark pharmaceuticals inc., usa
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 240 mg/1

Manufacturer
Glenmark Pharmaceuticals Inc., USA

Identifiers & Regulatory

Product NDC 68462-260
Product ID 68462-260_c4ac347e-78cd-490d-9047-73a1df2bd717
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078906
Listing Expiration 2026-12-31
Marketing Start 2009-09-17

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68462260
Hyphenated Format 68462-260

Supplemental Identifiers

RxCUI
897640 897649 897659
UPC
0368462292013 0368462293010 0368462260012
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA078906 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 240 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-01)
  • 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-05)
  • 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-10)
  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-30)
  • 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-90)
source: ndc

Packages (5)

68462-260-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-01) 68462-260-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-05) 68462-260-10 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-10) 68462-260-30 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-30) 68462-260-90 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-90)

Ingredients (1)

verapamil hydrochloride (240 mg/1)

Linked Drug Pages (1)

verapamil hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c4ac347e-78cd-490d-9047-73a1df2bd717", "openfda": {"upc": ["0368462292013", "0368462293010", "0368462260012"], "unii": ["V3888OEY5R"], "rxcui": ["897640", "897649", "897659"], "spl_set_id": ["ba1bf1ae-9347-4d17-998b-14bf7b5984ce"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-01)", "package_ndc": "68462-260-01", "marketing_start_date": "20090917"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-05)", "package_ndc": "68462-260-05", "marketing_start_date": "20090917"}, {"sample": false, "description": "1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-10)", "package_ndc": "68462-260-10", "marketing_start_date": "20090917"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-30)", "package_ndc": "68462-260-30", "marketing_start_date": "20090917"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-90)", "package_ndc": "68462-260-90", "marketing_start_date": "20090917"}], "brand_name": "verapamil hydrochloride", "product_id": "68462-260_c4ac347e-78cd-490d-9047-73a1df2bd717", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68462-260", "generic_name": "verapamil hydrochloride", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA078906", "marketing_category": "ANDA", "marketing_start_date": "20090917", "listing_expiration_date": "20261231"}